ACM Research (ACMR) Financials

$23.29 +0.88 (+3.93%)

Closing price 05/27/2025 04:00 PM Eastern

Extended Trading

$23.28 -0.01 (-0.04%)

As of 04:25 AM Eastern

Annual Income Statements for ACM Research

This table shows ACM Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Net Income / (Loss) Attributable to Common Shareholders	104	77	39	38	19	19	6.57	-0.32	1.03
Consolidated Net Income / (Loss)	131	97	51	43	22	19	6.57	-0.87	2.39
Net Income / (Loss) Continuing Operations	131	97	51	43	22	19	6.57	-0.87	2.39
Total Pre-Tax Income	166	116	67	43	19	19	7.38	-0.33	2.98
Total Operating Income	151	96	59	39	21	18	6.47	0.70	3.49
Total Gross Profit	392	276	184	115	70	51	34	17	13
Total Revenue	782	558	389	260	157	108	75	37	27
Operating Revenue	782	558	389	260	157	108	75	37	27
Total Cost of Revenue	391	282	205	145	87	57	40	19	14
Operating Cost of Revenue	391	282	205	145	87	57	40	19	14
Total Operating Expenses	241	180	125	76	48	33	28	17	9.84
Selling, General & Admin Expense	70	41	22	15	12	8.06	7.99	5.89	2.67
Marketing Expense	65	47	40	27	17	12	9.61	5.50	3.91
Research & Development Expense	105	93	62	34	19	13	10	5.14	3.26
Total Other Income / (Expense), net	15	20	8.33	4.35	-2.20	1.15	0.91	-1.03	-0.51
Interest Expense	4.15	2.68	1.66	0.77	0.98	0.75	0.50	1.07	0.52
Interest & Investment Income	10	18	13	5.14	1.55	0.50	0.15	0.05	0.02
Other Income / (Expense), net	9.10	4.75	-3.42	-0.02	-2.77	1.39	1.26	-	-
Income Tax Expense	35	19	17	0.13	-2.38	-0.52	0.81	0.55	0.60
Net Income / (Loss) Attributable to Noncontrolling Interest	28	20	11	5.16	2.90	0.56	0.00	-0.55	1.36
Basic Earnings per Share	$1.67	$1.29	$0.66	$0.65	$0.34	$1.12	$0.42	($0.05)	$0.30
Weighted Average Basic Shares Outstanding	62.21M	60.16M	59.24M	57.65M	54.70M	16.80M	15.79M	6.87M	2.18M
Diluted Earnings per Share	$1.53	$1.16	$0.59	$0.58	$0.30	$0.99	$0.37	($0.05)	$0.18
Weighted Average Diluted Shares Outstanding	66.24M	64.87M	65.34M	65.36M	63.55M	19.14M	17.91M	6.87M	3.79M
Weighted Average Basic & Diluted Shares Outstanding	63.13M	61.10M	59.70M	19.58M	18.74M	18.14M	15.70M	12.99M	-

This table shows ACM Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	31	31	24	17	18	26	27	7.15	12	21
Consolidated Net Income / (Loss)	39	39	31	22	23	31	34	8.96	14	27
Net Income / (Loss) Continuing Operations	39	39	31	22	23	31	34	8.96	14	27
Total Pre-Tax Income	56	43	41	26	31	32	41	12	17	38
Total Operating Income	44	44	38	25	23	33	30	8.86	17	32
Total Gross Profit	111	105	97	79	79	89	69	40	54	66
Total Revenue	223	204	202	152	170	169	145	74	109	134
Operating Revenue	223	204	202	152	170	169	145	74	109	134
Total Cost of Revenue	113	99	106	73	91	80	76	34	55	68
Operating Cost of Revenue	113	99	106	73	91	80	76	34	55	68
Total Operating Expenses	67	61	59	54	56	55	38	31	37	34
Selling, General & Admin Expense	21	17	16	16	14	12	6.71	7.76	6.91	5.52
Marketing Expense	18	16	17	14	9.44	17	11	9.34	12	13
Research & Development Expense	28	28	26	24	32	26	20	14	18	16
Total Other Income / (Expense), net	12	-1.51	3.14	1.23	8.05	-1.46	11	2.98	0.17	5.91
Interest Expense	1.23	1.21	0.93	0.78	0.70	0.64	0.65	0.70	0.67	0.42
Interest & Investment Income	3.14	4.28	1.69	1.25	8.30	1.99	6.27	1.75	5.79	3.27
Other Income / (Expense), net	11	-4.58	2.39	0.76	0.46	-2.81	5.19	1.92	-4.95	3.06
Income Tax Expense	17	4.01	9.34	4.37	8.13	0.72	7.64	2.88	2.66	10
Net Income / (Loss) Attributable to Noncontrolling Interest	8.03	7.77	7.19	4.66	5.60	5.32	6.77	1.82	2.37	6.07
Basic Earnings per Share	$0.51	$0.49	$0.39	$0.28	$0.29	$0.43	$0.45	$0.12	$0.20	$0.35
Weighted Average Basic Shares Outstanding	62.21M	62.50M	62.18M	61.37M	60.16M	60.22M	59.90M	59.74M	59.24M	59.36M
Diluted Earnings per Share	$0.47	$0.45	$0.35	$0.26	$0.29	$0.39	$0.41	$0.11	$0.20	$0.32
Weighted Average Diluted Shares Outstanding	66.24M	66.67M	67.06M	66.24M	64.87M	65.45M	64.93M	65.06M	65.34M	65.61M
Weighted Average Basic & Diluted Shares Outstanding	63.13M	62.63M	62.47M	62.01M	61.10M	60.61M	60.02M	59.87M	59.70M	59.46M

This table details how cash moves in and out of ACM Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Net Change in Cash & Equivalents	228	-65	-315	491	-46	91	9.96	7.56	5.72
Net Cash From Operating Activities	152	-75	-62	-40	-14	9.40	6.91	-8.10	-7.35
Net Cash From Continuing Operating Activities	152	-75	-62	-40	-14	9.40	6.91	-8.10	-3.70
Net Income / (Loss) Continuing Operations	131	97	51	43	22	19	6.57	-0.87	2.39
Consolidated Net Income / (Loss)	131	97	51	43	22	19	6.57	-0.87	-2.39
Depreciation Expense	9.97	8.09	5.37	2.35	1.06	0.79	0.42	0.27	0.19
Non-Cash Adjustments To Reconcile Net Income	137	49	118	37	-0.26	4.40	3.24	1.59	-1.99
Changes in Operating Assets and Liabilities, net	-126	-229	-236	-123	-36	-15	-3.32	-9.09	0.49
Net Cash From Investing Activities	-12	-6.75	-266	-11	-70	-5.53	-2.07	-24	-0.81
Net Cash From Continuing Investing Activities	-12	-6.75	-266	-11	-70	-5.53	-2.07	-24	-0.81
Purchase of Property, Plant & Equipment	-82	-62	-91	-9.15	-5.21	-0.97	-1.83	-0.65	-0.80
Acquisitions	-3.49	-2.46	-1.43	-0.56	-0.32	-0.15	-0.24	-1.32	-0.02
Purchase of Investments	-26	-26	-5.28	-1.57	-15	-4.41	0.00	-0.95	0.00
Sale and/or Maturity of Investments	175	110	4.58	0.00	0.56	0.00	0.00	-	-
Other Investing Activities, net	-75	-26	-172	0.00	-50	0.00	0.00	-21	0.00
Net Cash From Financing Activities	92	19	46	539	33	87	5.12	39	11
Net Cash From Continuing Financing Activities	92	19	46	539	33	87	5.12	39	11
Repayment of Debt	-42	-57	-11	-42	-22	-14	-13	-11	-7.72
Payment of Dividends	-6.90	-3.95	0.00	-	-	-	-	-	-
Issuance of Debt	130	74	56	30	52	18	18	11	5.92
Other Financing Activities, net	11	6.14	1.31	5.25	2.75	-0.26	0.53	-0.14	3.31
Effect of Exchange Rate Changes	-4.84	-1.74	-33	3.91	4.57	-0.58	-	0.66	-0.32
Cash Interest Paid	4.15	2.68	1.66	0.77	0.98	0.75	0.50	0.28	0.18
Cash Income Taxes Paid	11	26	3.59	1.13	4.97	1.16	0.00	-	-

This table details how cash moves in and out of ACM Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	76	10	113	29	-24	-50	-2.85	12	-88	12
Net Cash From Operating Activities	89	12	62	-9.65	-38	-18	11	-30	-0.80	-0.10
Net Cash From Continuing Operating Activities	89	12	62	-9.65	-38	-18	11	-30	-0.80	-0.10
Net Income / (Loss) Continuing Operations	39	39	31	22	23	31	34	8.96	14	27
Consolidated Net Income / (Loss)	39	39	31	22	23	31	34	8.96	14	27
Depreciation Expense	2.89	2.39	2.17	2.52	2.07	2.07	2.24	1.71	1.26	1.55
Non-Cash Adjustments To Reconcile Net Income	48	24	42	23	-17	11	29	26	13	53
Changes in Operating Assets and Liabilities, net	-1.41	-54	-14	-57	-47	-62	-54	-67	-30	-82
Net Cash From Investing Activities	-21	-23	20	12	0.54	-49	-7.58	49	-107	-8.67
Net Cash From Continuing Investing Activities	-21	-23	20	12	0.54	-49	-7.58	49	-107	-8.67
Purchase of Property, Plant & Equipment	-11	-33	-13	-25	-12	-28	-6.74	-15	-71	-15
Acquisitions	-1.50	-0.83	-0.48	-0.67	-0.85	-0.33	-1.13	-0.16	-0.35	-0.63
Purchase of Investments	-17	-	-1.37	-7.40	-1.27	-23	-0.73	-0.73	-0.08	-
Sale and/or Maturity of Investments	16	21	47	91	18	12	0.73	79	0.09	4.49
Other Investing Activities, net	-5.92	-11	-13	-45	-3.19	-9.09	0.28	-14	-36	7.95
Net Cash From Financing Activities	15	19	31	27	12	3.60	4.87	-1.46	9.44	41
Net Cash From Continuing Financing Activities	15	19	31	27	12	3.60	4.87	-1.46	9.44	41
Repayment of Debt	-4.84	-33	-2.92	-1.48	-5.85	-50	0.59	-1.70	3.96	-9.68
Issuance of Debt	16	58	33	24	17	57	-	0.00	5.32	-
Other Financing Activities, net	4.61	0.05	1.64	4.80	0.85	0.77	4.28	0.24	0.16	0.40
Effect of Exchange Rate Changes	-7.46	2.97	0.21	-0.55	1.81	13	-11	-4.78	9.93	-20
Cash Interest Paid	1.23	1.21	0.93	0.78	0.70	0.64	0.65	0.70	0.67	0.42
Cash Income Taxes Paid	1.42	0.69	9.11	0.00	9.63	9.23	4.37	2.87	3.40	0.06

This table presents ACM Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Total Assets	1,856	1,491	1,236	1,052	341	218	103	68	44
Total Current Assets	1,483	1,176	964	953	261	198	96	63	40
Cash & Equivalents	407	182	248	563	72	58	27	18	10
Restricted Cash	3.87	1.08	0.50	0.52	-	60	0.00	-	-
Short-Term Investments	19	21	20	29	28	0.00	-	-	-
Accounts Receivable	430	326	216	125	66	34	28	29	18
Inventories, net	598	545	393	218	89	45	39	15	12
Prepaid Expenses	7.51	20	16	14	5.89	2.05	1.99	0.55	0.72
Other Current Assets	17	81	70	2.38	-	-	-	0.05	0.05
Plant, Property, & Equipment, net	269	202	83	14	8.19	3.62	3.71	2.34	2.26
Total Noncurrent Assets	103	113	189	85	72	16	3.31	2.64	1.86
Long-Term Investments	37	28	17	13	6.34	5.93	1.36	1.24	0.00
Intangible Assets	3.46	2.54	1.26	0.48	0.55	0.34	0.27	0.11	0.02
Noncurrent Deferred & Refundable Income Taxes	15	20	6.70	13	11	5.33	1.64	1.29	1.84
Other Noncurrent Operating Assets	48	62	163	59	54	4.08	0.04	0.00	-
Total Liabilities & Shareholders' Equity	1,856	1,491	1,236	1,052	341	218	103	68	44
Total Liabilities	760	565	423	241	133	60	51	28	24
Total Current Liabilities	641	501	396	206	103	54	46	22	17
Short-Term Debt	77	38	58	12	28	14	9.45	5.10	4.77
Accounts Payable	277	256	168	133	54	26	27	13	9.14
Current Deferred Revenue	252	185	158	56	1.34	9.13	-	0.14	0.22
Current Deferred & Payable Income Tax Liabilities	13	6.40	3.47	0.25	0.03	3.13	1.19	0.04	0.04
Other Current Liabilities	22	15	8.07	4.60	19	1.36	8.42	3.08	0.00
Total Noncurrent Liabilities	119	64	27	35	30	6.72	4.58	6.22	6.88
Long-Term Debt	106	54	19	23	18	0.00	-	-	-
Other Noncurrent Operating Liabilities	13	10	8.43	10	11	6.72	4.58	6.22	6.88
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Total Equity & Noncontrolling Interests	1,096	926	812	812	208	97	52	40	2.49
Total Preferred & Common Equity	905	767	675	676	141	97	52	40	-2.43
Total Common Equity	905	767	675	676	141	97	52	40	-2.44
Common Stock	677	630	604	595	102	83	57	50	7.62
Retained Earnings	260	157	94	64	34	16	-3.39	-9.96	-9.64
Accumulated Other Comprehensive Income / (Loss)	-63	-49	-41	9.11	4.86	-1.68	-0.86	0.12	-0.41
Other Equity Adjustments	31	30	17	8.31	-	-	-	-	-
Noncontrolling Interest	191	159	137	135	67	0.00	-	-	4.92

This table presents ACM Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,794	1,668	1,557	1,410	1,317	1,313	1,148
Total Current Assets	1,445	1,343	1,229	1,116	997	994	971
Cash & Equivalents	333	324	211	207	257	260	336
Restricted Cash	1.78	0.88	0.81	0.56	0.58	0.46	0.37
Short-Term Investments	20	20	19	22	6.38	13	14
Accounts Receivable	430	350	349	286	236	222	203
Inventories, net	629	603	581	507	471	473	328
Prepaid Expenses	11	19	20	18	19	19	18
Other Current Assets	20	27	48	76	6.00	5.31	71
Plant, Property, & Equipment, net	250	229	219	191	159	150	66
Total Noncurrent Assets	99	96	109	103	161	169	110
Long-Term Investments	34	32	31	22	16	17	19
Intangible Assets	2.84	2.84	2.80	2.16	2.11	1.23	0.87
Noncurrent Deferred & Refundable Income Taxes	13	21	21	16	11	13	6.58
Other Noncurrent Operating Assets	49	40	53	63	132	138	84
Total Liabilities & Shareholders' Equity	1,794	1,668	1,557	1,410	1,317	1,313	1,148
Total Liabilities	725	666	596	532	484	480	374
Total Current Liabilities	610	586	533	482	456	450	346
Short-Term Debt	64	74	61	41	57	59	53
Accounts Payable	302	275	259	225	179	188	139
Current Deferred Revenue	226	211	187	196	201	185	142
Current Deferred & Payable Income Tax Liabilities	6.80	11	11	11	10	8.58	8.56
Other Current Liabilities	11	15	15	9.36	9.49	9.79	3.37
Total Noncurrent Liabilities	115	80	63	50	27	30	28
Long-Term Debt	106	71	53	40	16	18	19
Other Noncurrent Operating Liabilities	8.99	9.18	9.30	10	11	12	7.99
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,069	1,001	961	878	833	833	774
Total Preferred & Common Equity	888	833	796	729	692	692	643
Total Common Equity	888	833	796	729	692	692	643
Common Stock	670	659	647	620	613	606	601
Retained Earnings	229	198	174	152	124	101	91
Accumulated Other Comprehensive Income / (Loss)	-41	-55	-55	-60	-62	-33	-58
Other Equity Adjustments	30	30	30	17	17	17	8.31
Noncontrolling Interest	181	168	165	149	141	141	131

This table displays calculated financial ratios and metrics derived from ACM Research's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	40.23%	43.44%	49.69%	65.84%	45.66%	44.05%	104.47%	33.37%	0.00%
EBITDA Growth	56.47%	78.24%	48.61%	107.44%	-0.96%	145.27%	738.62%	-73.59%	0.00%
EBIT Growth	59.15%	80.88%	43.78%	106.56%	-2.39%	148.30%	1,003.71%	-79.94%	0.00%
NOPAT Growth	49.23%	80.24%	14.86%	59.79%	32.10%	217.08%	1,076.38%	-82.46%	0.00%
Net Income Growth	35.54%	91.54%	17.81%	98.00%	11.40%	195.98%	853.90%	-136.53%	0.00%
EPS Growth	31.90%	96.61%	1.72%	98.00%	11.40%	167.57%	840.00%	-127.78%	0.00%
Operating Cash Flow Growth	302.40%	-21.11%	-55.12%	-195.95%	-244.07%	36.10%	185.29%	-10.16%	0.00%
Free Cash Flow Firm Growth	191.41%	67.57%	-474.56%	27.27%	-1,942.83%	376.85%	85.65%	0.00%	0.00%
Invested Capital Growth	3.19%	30.31%	149.86%	63.59%	210.99%	42.53%	27.86%	71.59%	0.00%
Revenue Q/Q Growth	7.29%	12.46%	3.57%	23.59%	15.44%	3.62%	5.15%	0.00%	0.00%
EBITDA Q/Q Growth	22.74%	13.49%	-8.60%	40.61%	21.96%	3.06%	0.98%	0.00%	0.00%
EBIT Q/Q Growth	23.72%	13.68%	-10.10%	41.67%	22.84%	2.28%	1.71%	0.00%	0.00%
NOPAT Q/Q Growth	11.88%	3.80%	-5.27%	27.48%	15.69%	15.42%	-16.95%	0.00%	0.00%
Net Income Q/Q Growth	13.69%	10.39%	-8.06%	28.11%	29.96%	10.92%	-14.10%	0.00%	0.00%
EPS Q/Q Growth	6.25%	-2.52%	-18.06%	28.11%	29.96%	-1.98%	-58.43%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	497.80%	-99.44%	36.32%	-329.58%	-321.39%	92.29%	198.15%	42.62%	0.00%
Free Cash Flow Firm Q/Q Growth	353.48%	32.83%	-31.23%	-1.05%	-1,768.86%	113.29%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-4.63%	11.20%	26.56%	28.46%	43.31%	-45.24%	-16.33%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	50.06%	49.53%	47.22%	44.22%	44.44%	47.11%	46.15%	47.18%	48.70%
EBITDA Margin	21.74%	19.49%	15.68%	15.80%	12.63%	18.57%	10.91%	2.66%	13.43%
Operating Margin	19.31%	17.18%	15.18%	14.90%	13.72%	16.55%	8.67%	1.92%	12.75%
EBIT Margin	20.47%	18.04%	14.30%	14.89%	11.96%	17.84%	10.35%	1.92%	12.75%
Profit (Net Income) Margin	16.78%	17.37%	13.00%	16.52%	13.84%	18.10%	8.81%	-2.39%	8.72%
Tax Burden Percent	78.94%	83.34%	75.06%	99.69%	112.35%	102.74%	89.08%	268.31%	80.05%
Interest Burden Percent	103.88%	115.53%	121.13%	111.32%	103.04%	98.73%	95.52%	-46.43%	85.44%
Effective Tax Rate	21.06%	16.66%	24.94%	0.31%	-12.35%	-2.74%	10.92%	0.00%	19.95%
Return on Invested Capital (ROIC)	14.93%	11.50%	10.50%	19.84%	24.77%	45.28%	19.43%	2.38%	18.41%
ROIC Less NNEP Spread (ROIC-NNEP)	9.25%	1.78%	8.89%	18.47%	27.66%	43.45%	14.51%	16.59%	26.02%
Return on Net Nonoperating Assets (RNNOA)	-1.94%	-0.36%	-4.27%	-11.42%	-12.91%	-26.73%	-5.17%	-5.27%	-6.78%
Return on Equity (ROE)	12.98%	11.14%	6.23%	8.42%	11.86%	18.55%	14.26%	-2.89%	11.63%
Cash Return on Invested Capital (CROIC)	11.78%	-14.82%	-75.17%	-28.41%	-77.91%	10.21%	-5.02%	-50.34%	0.00%
Operating Return on Assets (OROA)	9.57%	7.38%	4.86%	5.55%	6.70%	11.96%	9.04%	1.25%	7.85%
Return on Assets (ROA)	7.84%	7.10%	4.42%	6.16%	7.76%	12.13%	7.69%	-1.55%	5.37%
Return on Common Equity (ROCE)	10.74%	9.25%	5.18%	6.75%	7.73%	13.23%	14.26%	-1.79%	-1.38%
Return on Equity Simple (ROE_SIMPLE)	14.51%	12.62%	7.49%	6.35%	15.36%	19.99%	12.56%	-2.19%	-98.07%
Net Operating Profit after Tax (NOPAT)	119	80	44	39	24	18	5.76	0.49	2.79
NOPAT Margin	15.24%	14.32%	11.40%	14.85%	15.42%	17.00%	7.72%	1.34%	10.21%
Net Nonoperating Expense Percent (NNEP)	5.68%	9.72%	1.60%	1.38%	-2.89%	1.83%	4.93%	-14.21%	-7.61%
Return On Investment Capital (ROIC_SIMPLE)	9.32%	7.84%	4.98%	-	-	-	-	-	-
Cost of Revenue to Revenue	49.94%	50.47%	52.78%	55.78%	55.56%	52.89%	53.85%	52.82%	51.30%
SG&A Expenses to Revenue	8.90%	7.29%	5.78%	5.86%	7.80%	7.50%	10.70%	16.13%	9.77%
R&D to Revenue	13.49%	16.62%	16.00%	13.17%	12.21%	12.00%	13.91%	14.07%	11.91%
Operating Expenses to Revenue	30.76%	32.34%	32.04%	29.32%	30.72%	30.56%	37.48%	45.27%	35.95%
Earnings before Interest and Taxes (EBIT)	160	101	56	39	19	19	7.73	0.70	3.49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	170	109	61	41	20	20	8.14	0.97	3.68
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.05	1.54	0.68	2.46	10.63	3.45	3.33	2.02	0.00
Price to Tangible Book Value (P/TBV)	1.05	1.55	0.68	2.46	10.67	3.46	3.35	2.03	0.00
Price to Revenue (P/Rev)	1.21	2.12	1.18	6.40	9.58	3.12	2.33	2.21	0.00
Price to Earnings (P/E)	9.13	15.31	11.68	44.06	79.89	17.77	26.49	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	10.96%	6.53%	8.56%	2.27%	1.25%	5.63%	3.78%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.05	1.53	0.64	5.09	10.21	6.03	4.66	2.56	0.00
Enterprise Value to Revenue (EV/Rev)	1.09	2.16	0.99	4.73	9.62	2.66	2.08	1.83	0.00
Enterprise Value to EBITDA (EV/EBITDA)	5.01	11.07	6.34	29.94	76.17	14.31	19.05	68.73	0.00
Enterprise Value to EBIT (EV/EBIT)	5.32	11.96	6.95	31.76	80.46	14.90	20.07	95.34	0.00
Enterprise Value to NOPAT (EV/NOPAT)	7.15	15.06	8.73	31.84	62.40	15.64	26.90	136.20	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	5.59	0.00	0.00	0.00	0.00	30.40	22.45	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	9.06	0.00	0.00	0.00	0.00	69.35	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.17	0.10	0.09	0.04	0.22	0.09	0.18	0.13	0.23
Long-Term Debt to Equity	0.10	0.06	0.02	0.03	0.09	0.00	0.00	0.00	0.00
Financial Leverage	-0.21	-0.20	-0.48	-0.62	-0.47	-0.62	-0.36	-0.32	-0.26
Leverage Ratio	1.66	1.57	1.41	1.37	1.53	1.53	1.85	1.86	2.17
Compound Leverage Factor	1.72	1.81	1.71	1.52	1.58	1.51	1.77	-0.86	1.85
Debt to Total Capital	14.30%	9.04%	8.66%	4.13%	18.01%	8.03%	15.29%	11.33%	18.87%
Short-Term Debt to Total Capital	6.04%	3.74%	6.56%	1.42%	10.93%	8.03%	15.29%	11.33%	18.87%
Long-Term Debt to Total Capital	8.25%	5.30%	2.10%	2.71%	7.08%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	14.96%	15.59%	15.44%	16.00%	26.40%	35.13%	0.00%	0.00%	90.76%
Common Equity to Total Capital	70.74%	75.36%	75.90%	79.87%	55.60%	56.83%	84.71%	88.66%	-9.63%
Debt to EBITDA	1.08	0.85	1.26	0.85	2.31	0.69	1.16	5.25	1.30
Net Debt to EBITDA	-1.68	-1.29	-3.43	-13.90	-3.07	-5.51	-2.34	-14.24	-1.45
Long-Term Debt to EBITDA	0.62	0.50	0.31	0.56	0.91	0.00	0.00	0.00	0.00
Debt to NOPAT	1.53	1.15	1.74	0.91	1.89	0.75	1.64	10.40	1.71
Net Debt to NOPAT	-2.39	-1.76	-4.72	-14.78	-2.51	-6.02	-3.30	-28.21	-1.91
Long-Term Debt to NOPAT	0.89	0.68	0.42	0.60	0.74	0.00	0.00	0.00	0.00
Altman Z-Score	2.19	2.55	1.77	5.45	8.10	5.03	3.57	2.82	0.00
Noncontrolling Interest Sharing Ratio	17.31%	17.03%	16.80%	19.85%	34.78%	28.67%	0.00%	38.02%	111.87%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	2.31	2.35	2.43	4.63	2.53	3.71	2.08	2.88	2.36
Quick Ratio	1.34	1.06	1.22	3.48	1.61	1.72	1.20	2.15	1.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	94	-103	-317	-55	-76	4.12	-1.49	-10	0.00
Operating Cash Flow to CapEx	184.87%	-121.73%	-68.27%	-438.03%	-259.97%	968.38%	377.54%	-1,244.39%	-933.25%
Free Cash Flow to Firm to Interest Expense	22.67	-38.39	-191.77	-72.21	-77.35	5.53	-2.99	-9.68	0.00
Operating Cash Flow to Interest Expense	36.73	-28.10	-37.58	-52.41	-13.80	12.62	13.87	-7.56	-14.03
Operating Cash Flow Less CapEx to Interest Expense	16.86	-51.17	-92.62	-64.37	-19.10	11.32	10.20	-8.17	-15.54
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.47	0.41	0.34	0.37	0.56	0.67	0.87	0.65	0.62
Accounts Receivable Turnover	2.07	2.06	2.28	2.72	3.14	3.48	2.60	1.55	1.54
Inventory Turnover	0.68	0.60	0.67	0.94	1.30	1.36	1.48	1.43	1.20
Fixed Asset Turnover	3.32	3.92	8.02	23.37	26.52	29.35	24.68	15.87	12.10
Accounts Payable Turnover	1.46	1.33	1.36	1.55	2.16	2.14	1.98	1.71	1.54
Days Sales Outstanding (DSO)	176.31	177.21	159.77	133.95	116.30	104.98	140.36	235.17	237.22
Days Inventory Outstanding (DIO)	534.27	608.47	543.62	386.37	279.83	268.15	245.88	256.07	303.24
Days Payable Outstanding (DPO)	249.18	275.25	268.11	236.15	168.91	170.78	184.07	213.84	237.48
Cash Conversion Cycle (CCC)	461.41	510.43	435.28	284.17	227.22	202.34	202.17	277.41	302.98
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	811	786	603	241	148	47	33	26	15
Invested Capital Turnover	0.98	0.80	0.92	1.34	1.61	2.66	2.52	1.77	1.80
Increase / (Decrease) in Invested Capital	25	183	362	94	100	14	7.25	11	0.00
Enterprise Value (EV)	852	1,203	387	1,229	1,507	286	155	67	0.00
Market Capitalization	946	1,184	458	1,663	1,500	336	174	81	0.00
Book Value per Share	$14.44	$12.66	$11.35	$34.66	$7.64	$5.35	$3.27	$2.60	($1.12)
Tangible Book Value per Share	$14.39	$12.62	$11.33	$34.64	$7.61	$5.33	$3.25	$2.59	($1.13)
Total Capital	1,279	1,018	889	847	254	171	62	45	25
Total Debt	183	92	77	35	46	14	9.45	5.10	4.77
Total Long-Term Debt	106	54	19	23	18	0.00	0.00	0.00	0.00
Net Debt	-285	-140	-209	-570	-61	-110	-19	-14	-5.35
Capital Expenditures (CapEx)	82	62	91	9.15	5.21	0.97	1.83	0.65	0.79
Debt-free, Cash-free Net Working Capital (DFCFNWC)	489	509	357	166	85	41	32	29	18
Debt-free Net Working Capital (DFNWC)	919	714	626	759	185	159	59	46	28
Net Working Capital (NWC)	842	675	568	747	158	145	50	41	23
Net Nonoperating Expense (NNE)	-12	-17	-6.25	-4.34	2.47	-1.18	-0.81	1.36	0.41
Net Nonoperating Obligations (NNO)	-285	-140	-209	-570	-61	-110	-19	-14	-5.35
Total Depreciation and Amortization (D&A)	9.97	8.09	5.37	2.35	1.06	0.79	0.42	0.27	0.19
Debt-free, Cash-free Net Working Capital to Revenue	62.49%	91.28%	91.88%	64.07%	54.58%	37.93%	43.15%	78.10%	65.51%
Debt-free Net Working Capital to Revenue	117.56%	127.94%	160.97%	292.20%	118.43%	147.55%	79.49%	126.53%	102.48%
Net Working Capital to Revenue	107.68%	121.11%	145.97%	287.58%	100.72%	134.76%	66.84%	112.58%	85.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.67	$1.29	$0.66	$0.65	$0.34	$0.37	$0.14	($0.02)	$0.10
Adjusted Weighted Average Basic Shares Outstanding	62.21M	60.16M	59.24M	57.65M	54.70M	50.40M	47.37M	20.60M	6.53M
Adjusted Diluted Earnings per Share	$1.53	$1.16	$0.59	$0.58	$0.30	$0.33	$0.12	($0.02)	$0.06
Adjusted Weighted Average Diluted Shares Outstanding	66.24M	64.87M	65.34M	65.36M	63.55M	57.41M	53.74M	20.60M	11.38M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.37	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	63.13M	61.10M	59.70M	58.74M	56.23M	54.41M	42.53M	38.98M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	119	80	44	39	15	12	5.76	0.49	2.79
Normalized NOPAT Margin	15.24%	14.32%	11.40%	14.85%	9.61%	11.58%	7.72%	1.34%	10.21%
Pre Tax Income Margin	21.26%	20.84%	17.32%	16.58%	12.32%	17.61%	9.89%	-0.89%	10.89%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	38.57	37.52	33.60	50.56	19.07	25.75	15.51	0.65	6.66
NOPAT to Interest Expense	28.71	29.79	26.78	50.43	24.59	24.53	11.57	0.46	5.33
EBIT Less CapEx to Interest Expense	18.70	14.44	-21.44	38.59	13.76	24.45	11.84	0.05	5.16
NOPAT Less CapEx to Interest Expense	8.85	6.71	-28.27	38.47	19.28	23.23	7.90	-0.15	3.83
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	5.26%	4.08%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	5.26%	4.08%	0.00%	0.00%	0.00%	14.53%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from ACM Research's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	31.21%	21.00%	40.05%	104.95%	56.92%	26.07%	38.49%	76.02%	14.08%	99.53%
EBITDA Growth	121.67%	29.50%	11.33%	128.10%	99.46%	-10.54%	61.38%	206.69%	-30.65%	224.01%
EBIT Growth	128.79%	30.45%	12.25%	141.01%	103.27%	-12.50%	61.04%	183.42%	-34.76%	226.69%
NOPAT Growth	75.94%	23.48%	16.87%	214.07%	23.44%	42.11%	80.49%	202.97%	-14.17%	88.81%
Net Income Growth	67.85%	24.77%	-6.54%	146.48%	64.27%	14.47%	100.60%	220.42%	-23.81%	142.83%
EPS Growth	62.07%	15.38%	-14.63%	136.36%	45.00%	21.88%	127.78%	210.00%	-25.93%	113.33%
Operating Cash Flow Growth	331.00%	166.83%	442.70%	68.36%	-4,712.17%	-17,725.00%	133.81%	-9.97%	97.80%	97.54%
Free Cash Flow Firm Growth	103.25%	47.60%	21.83%	7.97%	52.40%	25.60%	45.47%	32.57%	-348.78%	-264.89%
Invested Capital Growth	3.19%	20.33%	22.99%	31.36%	30.31%	48.31%	37.84%	45.90%	149.86%	153.62%
Revenue Q/Q Growth	9.56%	0.74%	33.04%	-10.64%	1.04%	16.59%	94.70%	-31.59%	-18.82%	28.08%
EBITDA Q/Q Growth	36.72%	-0.37%	47.84%	10.07%	-20.13%	-14.35%	202.92%	-3.75%	-64.18%	54.51%
EBIT Q/Q Growth	37.66%	-0.94%	53.83%	9.07%	-21.51%	-14.76%	230.29%	-8.01%	-66.21%	56.88%
NOPAT Q/Q Growth	-23.85%	38.16%	37.55%	21.57%	-46.55%	30.77%	269.64%	-52.22%	-38.47%	66.08%
Net Income Q/Q Growth	1.12%	23.16%	42.13%	-5.18%	-24.83%	-7.75%	274.84%	-36.80%	-47.62%	61.67%
EPS Q/Q Growth	4.44%	28.57%	34.62%	-10.34%	-25.64%	-4.88%	272.73%	-45.00%	-37.50%	77.78%
Operating Cash Flow Q/Q Growth	643.68%	-80.66%	738.31%	70.94%	-115.16%	-257.06%	137.22%	-3,726.10%	-697.00%	99.70%
Free Cash Flow Firm Q/Q Growth	105.20%	9.85%	33.60%	-4.62%	16.33%	-34.50%	21.83%	45.90%	-30.79%	1.43%
Invested Capital Q/Q Growth	-4.63%	10.45%	-5.35%	3.50%	11.20%	12.89%	1.09%	2.68%	26.56%	4.92%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.59%	51.40%	47.80%	51.99%	46.43%	52.51%	47.48%	53.85%	49.57%	49.34%
EBITDA Margin	25.69%	20.59%	20.82%	18.73%	15.21%	19.24%	26.19%	16.83%	11.96%	27.11%
Operating Margin	19.68%	21.66%	18.57%	16.58%	13.72%	19.68%	21.05%	11.93%	15.36%	23.66%
EBIT Margin	24.40%	19.42%	19.75%	17.08%	13.99%	18.01%	24.64%	14.52%	10.80%	25.95%
Profit (Net Income) Margin	17.50%	18.96%	15.51%	14.52%	13.68%	18.39%	23.24%	12.07%	13.07%	20.25%
Tax Burden Percent	69.31%	90.61%	77.08%	83.49%	74.13%	97.74%	81.48%	75.69%	84.21%	72.11%
Interest Burden Percent	103.50%	107.76%	101.89%	101.81%	131.89%	104.45%	115.77%	109.81%	143.67%	108.21%
Effective Tax Rate	30.69%	9.39%	22.92%	16.51%	25.87%	2.26%	18.52%	24.31%	15.79%	27.89%
Return on Invested Capital (ROIC)	13.36%	18.38%	14.22%	12.28%	8.17%	16.12%	14.64%	7.29%	11.91%	19.28%
ROIC Less NNEP Spread (ROIC-NNEP)	9.31%	19.08%	13.12%	11.71%	4.75%	16.73%	11.38%	6.53%	11.87%	16.86%
Return on Net Nonoperating Assets (RNNOA)	-1.96%	-3.82%	-3.14%	-2.36%	-0.96%	-4.75%	-3.80%	-2.38%	-5.70%	-5.84%
Return on Equity (ROE)	11.41%	14.56%	11.08%	9.93%	7.22%	11.37%	10.85%	4.91%	6.21%	13.44%
Cash Return on Invested Capital (CROIC)	11.78%	-4.77%	-6.48%	-13.94%	-14.82%	-25.90%	-19.17%	-26.40%	-75.17%	-72.80%
Operating Return on Assets (OROA)	11.40%	8.83%	9.18%	7.57%	5.72%	6.98%	9.51%	5.09%	3.67%	12.05%
Return on Assets (ROA)	8.18%	8.63%	7.21%	6.43%	5.60%	7.13%	8.97%	4.23%	4.44%	9.40%
Return on Common Equity (ROCE)	9.43%	12.09%	9.21%	8.24%	5.99%	9.45%	9.01%	4.08%	5.17%	10.79%
Return on Equity Simple (ROE_SIMPLE)	0.00%	13.00%	12.94%	13.81%	0.00%	12.03%	12.11%	9.68%	0.00%	8.55%
Net Operating Profit after Tax (NOPAT)	30	40	29	21	17	32	25	6.71	14	23
NOPAT Margin	13.64%	19.63%	14.31%	13.84%	10.17%	19.23%	17.15%	9.03%	12.93%	17.06%
Net Nonoperating Expense Percent (NNEP)	4.05%	-0.70%	1.10%	0.57%	3.42%	-0.61%	3.26%	0.75%	0.04%	2.42%
Return On Investment Capital (ROIC_SIMPLE)	2.38%	-	-	-	1.70%	-	-	-	1.58%	-
Cost of Revenue to Revenue	50.41%	48.60%	52.20%	48.01%	53.57%	47.49%	52.52%	46.15%	50.43%	50.66%
SG&A Expenses to Revenue	9.26%	8.36%	7.95%	10.38%	8.10%	7.35%	4.64%	10.45%	6.36%	4.13%
R&D to Revenue	12.42%	13.65%	12.83%	15.72%	19.06%	15.51%	13.88%	18.89%	16.43%	11.73%
Operating Expenses to Revenue	29.90%	29.73%	29.23%	35.41%	32.70%	32.83%	26.43%	41.91%	34.21%	25.68%
Earnings before Interest and Taxes (EBIT)	55	40	40	26	24	30	36	11	12	35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	57	42	42	29	26	32	38	12	13	36
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.05	1.43	1.72	2.22	1.54	1.49	1.13	1.01	0.68	1.15
Price to Tangible Book Value (P/TBV)	1.05	1.43	1.72	2.23	1.55	1.50	1.14	1.01	0.68	1.15
Price to Revenue (P/Rev)	1.21	1.74	2.06	2.78	2.12	2.19	1.70	1.66	1.18	1.97
Price to Earnings (P/E)	9.13	14.05	16.82	20.15	15.31	15.21	11.73	13.38	11.68	17.17
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	10.96%	7.12%	5.95%	4.96%	6.53%	6.58%	8.53%	7.47%	8.56%	5.83%
Enterprise Value to Invested Capital (EV/IC)	1.05	1.45	1.78	2.19	1.53	1.51	1.15	1.01	0.64	1.20
Enterprise Value to Revenue (EV/Rev)	1.09	1.69	1.97	2.81	2.16	2.15	1.56	1.49	0.99	1.52
Enterprise Value to EBITDA (EV/EBITDA)	5.01	8.88	10.60	14.30	11.07	11.11	7.20	7.35	6.34	8.57
Enterprise Value to EBIT (EV/EBIT)	5.32	9.51	11.37	15.40	11.96	12.03	7.73	7.89	6.95	9.25
Enterprise Value to NOPAT (EV/NOPAT)	7.15	11.55	13.84	18.91	15.06	13.83	10.50	10.97	8.73	12.23
Enterprise Value to Operating Cash Flow (EV/OCF)	5.59	48.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	9.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.17	0.16	0.14	0.12	0.10	0.09	0.09	0.09	0.09	0.09
Long-Term Debt to Equity	0.10	0.10	0.07	0.06	0.06	0.05	0.02	0.02	0.02	0.02
Financial Leverage	-0.21	-0.20	-0.24	-0.20	-0.20	-0.28	-0.33	-0.36	-0.48	-0.35
Leverage Ratio	1.66	1.65	1.63	1.60	1.57	1.55	1.47	1.46	1.41	1.59
Compound Leverage Factor	1.71	1.77	1.66	1.63	2.07	1.62	1.71	1.61	2.02	1.72
Debt to Total Capital	14.30%	13.76%	12.64%	10.66%	9.04%	8.39%	8.07%	8.50%	8.66%	8.48%
Short-Term Debt to Total Capital	6.04%	5.20%	6.47%	5.70%	3.74%	4.24%	6.31%	6.50%	6.56%	6.26%
Long-Term Debt to Total Capital	8.25%	8.56%	6.18%	4.97%	5.30%	4.15%	1.75%	2.00%	2.10%	2.22%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	14.96%	14.59%	14.67%	15.30%	15.59%	15.55%	15.60%	15.47%	15.44%	15.50%
Common Equity to Total Capital	70.74%	71.65%	72.68%	74.03%	75.36%	76.06%	76.33%	76.03%	75.90%	76.02%
Debt to EBITDA	1.08	1.23	1.12	0.92	0.85	0.84	0.73	0.91	1.26	1.08
Net Debt to EBITDA	-1.68	-1.58	-1.79	-1.18	-1.29	-1.79	-2.08	-2.51	-3.43	-4.46
Long-Term Debt to EBITDA	0.62	0.77	0.55	0.43	0.50	0.42	0.16	0.21	0.31	0.28
Debt to NOPAT	1.53	1.60	1.47	1.22	1.15	1.04	1.07	1.36	1.74	1.53
Net Debt to NOPAT	-2.39	-2.05	-2.34	-1.56	-1.76	-2.23	-3.04	-3.74	-4.72	-6.36
Long-Term Debt to NOPAT	0.89	1.00	0.72	0.57	0.68	0.52	0.23	0.32	0.42	0.40
Altman Z-Score	2.01	2.27	2.49	2.93	2.38	2.34	2.04	1.83	1.65	2.38
Noncontrolling Interest Sharing Ratio	17.31%	16.95%	16.88%	17.03%	17.03%	16.96%	16.88%	16.76%	16.80%	19.73%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.31	2.37	2.29	2.31	2.35	2.32	2.18	2.21	2.43	2.81
Quick Ratio	1.34	1.28	1.18	1.09	1.06	1.07	1.10	1.10	1.22	1.60
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	5.38	-104	-115	-173	-165	-198	-147	-188	-348	-266
Operating Cash Flow to CapEx	776.06%	36.62%	470.41%	-37.96%	-310.78%	-63.88%	168.43%	-204.73%	-1.13%	-0.65%
Free Cash Flow to Firm to Interest Expense	4.38	-85.78	-123.34	-221.09	-237.41	-309.01	-226.57	-270.65	-519.68	-634.40
Operating Cash Flow to Interest Expense	72.15	9.86	66.08	-12.32	-55.03	-27.85	17.49	-43.88	-1.19	-0.24
Operating Cash Flow Less CapEx to Interest Expense	62.85	-17.07	52.04	-44.79	-72.73	-71.45	7.10	-65.31	-106.64	-36.74
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.47	0.46	0.46	0.44	0.41	0.39	0.39	0.35	0.34	0.46
Accounts Receivable Turnover	2.07	2.04	2.37	2.23	2.06	2.03	2.26	2.39	2.28	2.49
Inventory Turnover	0.68	0.65	0.65	0.61	0.60	0.59	0.61	0.58	0.67	0.79
Fixed Asset Turnover	3.32	3.31	3.58	3.45	3.92	3.85	4.26	4.06	8.02	9.82
Accounts Payable Turnover	1.46	1.40	1.54	1.43	1.33	1.35	1.45	1.30	1.36	1.55
Days Sales Outstanding (DSO)	176.31	179.17	154.29	164.03	177.21	180.03	161.18	152.74	159.77	146.53
Days Inventory Outstanding (DIO)	534.27	561.68	559.92	600.78	608.47	622.16	595.43	626.46	543.62	459.86
Days Payable Outstanding (DPO)	249.18	260.21	236.74	254.52	275.25	271.11	251.68	280.01	268.11	235.19
Cash Conversion Cycle (CCC)	461.41	480.64	477.47	510.29	510.43	531.08	504.93	499.18	435.28	371.20
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	811	850	770	813	786	707	626	619	603	477
Invested Capital Turnover	0.98	0.94	0.99	0.89	0.80	0.84	0.85	0.81	0.92	1.13
Increase / (Decrease) in Invested Capital	25	144	144	194	183	230	172	195	362	289
Enterprise Value (EV)	852	1,230	1,367	1,783	1,203	1,064	717	626	387	572
Market Capitalization	946	1,268	1,430	1,766	1,184	1,087	783	699	458	738
Book Value per Share	$14.44	$14.22	$13.44	$12.97	$12.66	$12.15	$11.56	$11.59	$11.35	$10.85
Tangible Book Value per Share	$14.39	$14.17	$13.39	$12.93	$12.62	$12.11	$11.52	$11.57	$11.33	$10.83
Total Capital	1,279	1,240	1,146	1,075	1,018	959	906	910	889	846
Total Debt	183	171	145	115	92	80	73	77	77	72
Total Long-Term Debt	106	106	71	53	54	40	16	18	19	19
Net Debt	-285	-219	-231	-147	-140	-171	-207	-213	-209	-298
Capital Expenditures (CapEx)	11	33	13	25	12	28	6.74	15	71	15
Debt-free, Cash-free Net Working Capital (DFCFNWC)	489	544	487	527	509	445	333	329	357	328
Debt-free Net Working Capital (DFNWC)	919	900	831	757	714	675	598	603	626	679
Net Working Capital (NWC)	842	835	757	696	675	634	541	544	568	626
Net Nonoperating Expense (NNE)	-8.62	1.36	-2.42	-1.03	-5.97	1.43	-8.80	-2.26	-0.15	-4.26
Net Nonoperating Obligations (NNO)	-285	-219	-231	-147	-140	-171	-207	-213	-209	-298
Total Depreciation and Amortization (D&A)	2.89	2.39	2.17	2.52	2.07	2.07	2.24	1.71	1.26	1.55
Debt-free, Cash-free Net Working Capital to Revenue	62.49%	74.65%	70.16%	82.84%	91.28%	89.74%	72.30%	78.20%	91.88%	87.31%
Debt-free Net Working Capital to Revenue	117.56%	123.43%	119.83%	119.15%	127.94%	136.02%	129.64%	143.20%	160.97%	180.75%
Net Working Capital to Revenue	107.68%	114.58%	109.15%	109.51%	121.11%	127.83%	117.23%	129.15%	145.97%	166.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.51	$0.49	$0.39	$0.28	$0.29	$0.43	$0.45	$0.12	$0.20	$0.35
Adjusted Weighted Average Basic Shares Outstanding	62.21M	62.50M	62.18M	61.37M	60.16M	60.22M	59.90M	59.74M	59.24M	59.36M
Adjusted Diluted Earnings per Share	$0.47	$0.45	$0.35	$0.26	$0.29	$0.39	$0.41	$0.11	$0.20	$0.32
Adjusted Weighted Average Diluted Shares Outstanding	66.24M	66.67M	67.06M	66.24M	64.87M	65.45M	64.93M	65.06M	65.34M	65.61M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.29	$0.00	$0.00	$0.00	$0.20	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	63.13M	62.63M	62.47M	62.01M	61.10M	60.61M	60.02M	59.87M	59.70M	59.46M
Normalized Net Operating Profit after Tax (NOPAT)	30	40	29	21	17	32	25	6.71	14	23
Normalized NOPAT Margin	13.64%	19.63%	14.31%	13.84%	10.17%	19.23%	17.15%	9.03%	12.93%	17.06%
Pre Tax Income Margin	25.25%	20.92%	20.12%	17.39%	18.45%	18.81%	28.52%	15.95%	15.52%	28.08%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	44.40	32.78	42.90	33.19	34.19	47.44	54.88	15.52	17.52	82.81
NOPAT to Interest Expense	24.83	33.14	31.09	26.90	24.86	50.66	38.20	9.65	20.98	54.45
EBIT Less CapEx to Interest Expense	35.10	5.85	28.85	0.73	16.48	3.84	44.50	-5.92	-87.92	46.31
NOPAT Less CapEx to Interest Expense	15.53	6.21	17.04	-5.56	7.16	7.06	27.82	-11.78	-84.46	17.95
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	5.26%	0.00%	0.00%	0.00%	4.08%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	5.26%	0.00%	0.00%	0.00%	4.08%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About ACM Research's Financials

When does ACM Research's fiscal year end?

According to the most recent income statement we have on file, ACM Research's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has ACM Research's net income changed over the last 8 years?

ACM Research's net income appears to be on an upward trend, with a most recent value of $131.27 million in 2024, rising from $2.39 million in 2016. The previous period was $96.85 million in 2023. View ACM Research's forecast to see where analysts expect ACM Research to go next.

What is ACM Research's operating income?

ACM Research's total operating income in 2024 was $151.00 million, based on the following breakdown:

Total Gross Profit: $391.55 million
Total Operating Expenses: $240.56 million

How has ACM Research revenue changed over the last 8 years?

Over the last 8 years, ACM Research's total revenue changed from $27.37 million in 2016 to $782.12 million in 2024, a change of 2,757.5%.

How much debt does ACM Research have?

ACM Research's total liabilities were at $759.82 million at the end of 2024, a 34.5% increase from 2023, and a 3,072.8% increase since 2016.

How much cash does ACM Research have?

In the past 8 years, ACM Research's cash and equivalents has ranged from $10.12 million in 2016 to $562.55 million in 2021, and is currently $407.45 million as of their latest financial filing in 2024.

How has ACM Research's book value per share changed over the last 8 years?

Over the last 8 years, ACM Research's book value per share changed from -1.12 in 2016 to 14.44 in 2024, a change of -1,390.5%.

Related Companies

This page (NASDAQ:ACMR) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ACM Research (ACMR) Financials

Frequently Asked Questions About ACM Research's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ACM Research (ACMR) Financials

Annual Income Statements for ACM Research

Quarterly Income Statements for ACM Research

Annual Cash Flow Statements for ACM Research

Quarterly Cash Flow Statements for ACM Research

Annual Balance Sheets for ACM Research

Quarterly Balance Sheets for ACM Research

Annual Metrics And Ratios for ACM Research

Quarterly Metrics And Ratios for ACM Research

Frequently Asked Questions About ACM Research's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools